25141968|t|The association between single nucleotide polymorphisms of GSK 3beta gene and sporadic Alzheimer's disease in a cohort of southern Chinese Han population.
25141968|a|Recent studies suggest that genetic factors contribute to the pathogenesis of sporadic Alzheimer's disease (sAD). Glycogen synthase kinase-3 beta (GSK 3beta) is an important molecule which regulates tau phosphorylation and neurofibrillary tangles formation. GSK 3beta gene may be a potential candidate gene for the risk of sAD. To investigate the association of the polymorphisms in GSK 3beta gene with sAD, we conducted a case-control study in a southern Chinese Han cohort including 302 sAD patients and 315 control participants. Four single nucleotide polymorphisms (SNPs) (rs3732361, rs56728675, rs60393216, and rs334558) within the promoter region of GSK 3beta gene were selected and genotyped with a polymerase chain reaction-ligase detection (PCR-LDR) method. Logistic regression was used to analyze the association between target SNPs and the risk of sAD. After adjusting for age, sex, and APOE epsilon4 status, no association was revealed between these SNPs and sAD (P > 0.05). The SNPs in the selected regions of GSK 3beta gene are unlikely to confer the susceptibility of sAD in southern Chinese Han population. Further studies with a larger sample size and different ethnic populations are needed to reveal the role of SNPs of GSK 3beta gene in the pathogenesis of sAD. 
25141968	59	68	GSK 3beta	Gene	2932
25141968	87	106	Alzheimer's disease	Disease	MESH:D000544
25141968	242	261	Alzheimer's disease	Disease	MESH:D000544
25141968	263	266	sAD	Disease	MESH:D000544
25141968	269	300	Glycogen synthase kinase-3 beta	Gene	2932
25141968	302	311	GSK 3beta	Gene	2932
25141968	354	357	tau	Gene	4137
25141968	378	401	neurofibrillary tangles	Disease	MESH:D055956
25141968	413	422	GSK 3beta	Gene	2932
25141968	478	481	sAD	Disease	MESH:D000544
25141968	538	547	GSK 3beta	Gene	2932
25141968	558	561	sAD	Disease	MESH:D000544
25141968	644	647	sAD	Disease	MESH:D000544
25141968	648	656	patients	Species	9606
25141968	732	741	rs3732361	SNP	tmVar:rs3732361;VariantGroup:2;CorrespondingGene:2932;RS#:3732361;CorrespondingSpecies:9606
25141968	743	753	rs56728675	SNP	tmVar:rs56728675;VariantGroup:0;CorrespondingGene:2932;RS#:56728675;CorrespondingSpecies:9606
25141968	755	765	rs60393216	SNP	tmVar:rs60393216;VariantGroup:1;CorrespondingGene:2932;RS#:60393216;CorrespondingSpecies:9606
25141968	771	779	rs334558	SNP	tmVar:rs334558;VariantGroup:3;CorrespondingGene:2932;RS#:334558;CorrespondingSpecies:9606
25141968	811	820	GSK 3beta	Gene	2932
25141968	1014	1017	sAD	Disease	MESH:D000544
25141968	1053	1057	APOE	Gene	348
25141968	1126	1129	sAD	Disease	MESH:D000544
25141968	1178	1187	GSK 3beta	Gene	2932
25141968	1238	1241	sAD	Disease	MESH:D000544
25141968	1394	1403	GSK 3beta	Gene	2932
25141968	1432	1435	sAD	Disease	MESH:D000544
25141968	Association	MESH:D000544	RS#:60393216;CorrespondingGene:2932
25141968	Association	MESH:D000544	RS#:56728675;CorrespondingGene:2932
25141968	Association	MESH:D000544	RS#:334558;CorrespondingGene:2932
25141968	Positive_Correlation	MESH:D000544	RS#:3732361;CorrespondingGene:2932
25141968	Association	MESH:D055956	2932
25141968	Association	2932	4137
25141968	Association	MESH:D000544	2932

